Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2003
11/20/2003US20030215550 Oligosaccharide for preventing natural pigment to discoloration; photostability, thermostability
11/20/2003US20030215533 Method of preventing respiratory infections
11/20/2003US20030215532 Cooling or heating sensitizers such as oleoresin or spilanthol, for use in foods, drugs or cosmetics
11/20/2003US20030215527 Novel substituted benzimidazole dosage forms and method of using same
11/20/2003US20030215525 Heat treated suspensions comprising group III compounds, preservatives, antideposit agents and optionally adjuvants, used for prophylaxis of gastrointestinal disorders
11/20/2003US20030215524 Stable pharmaceutical composition useful for treating gastrointestinal disorders
11/20/2003US20030215522 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
11/20/2003US20030215519 Preferential plugging of vascular sytems of mammals using microstructure particles comprising hydrolytically degradable crosslinked gels
11/20/2003US20030215518 Immediate release eplerenone compositions
11/20/2003US20030215508 Sustained release portion of unit dose containing guaifenesin, dextromethorphan and a release-delaying matrix contains a hydrophilic polymer and a water insoluble polymer, immediate release portion containing guaifenesin
11/20/2003US20030215505 Rapidly disintegrating tablet for oral administration containing a compacted mixture of methylcellulose having specific viscosity and an edible calcium salt
11/20/2003US20030215504 Directly compressible acetaminophen compositions
11/20/2003US20030215503 Palatable chewable tablet
11/20/2003US20030215502 Fast dissolving dosage forms having reduced friability
11/20/2003US20030215501 An oral formulation containing from about 10% to 90% of a gel-forming polysaccharide derived from psyllium seed husk (containing xylose and arabinose)and 10% to about 90% of a fast dissolving excipient
11/20/2003US20030215499 As a binder a low amylose starch, which has been fully debranched using isoamylase; good binding and disintegration properties
11/20/2003US20030215497 Adjuvant composition and methods for its use
11/20/2003US20030215496 Solid carrier includes a hydrophililc surfactant and a drug
11/20/2003US20030215495 Antihistamine formulations for soft capsule dosage forms
11/20/2003US20030215493 Composition and method for dermatological treatment
11/20/2003US20030215492 Administering a mammalian host for treating a disease caused by proliferation of eukaryotic cells a formulation containing a complex of lipid and a drug 7-ethyl-10-hydroxycamptothecin
11/20/2003US20030215487 Adhesive comprises N-methylpyrrolidone and oleoylsarcosine as penetration enhancers and polyurethane backing for application to non-scrotal skin
11/20/2003US20030215473 Comprises fractionated oat oil comprising galactolipids as emulsifier
11/20/2003US20030215467 Isolated from resected and washed human gastrointestinal tract; for oral administration; probiotics
11/20/2003US20030215460 Methods and compositions for inducing an immune response
11/20/2003US20030215449 Method of treating or delaying onset of angiogenic-associated disorder comprising administering to subject an antibody to the polypeptide of SEC1 in an amount sufficient to treat or prevent said angiogenic associated disorder
11/20/2003US20030215447 Produced by hybridoma cell line DSM ACC 2533
11/20/2003US20030215436 Anitmicrobial polymer conjugates
11/20/2003US20030215421 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
11/20/2003US20030215419 An endcapped acrylamide polymer or polysiloxanes covalently bind to a biomaterial surface, and an attached aliphatic fatty acid bind to a proteinaceous albumin; adjust an implantable medical device in order to be biocompatible
11/20/2003US20030215412 Induction of hair growth with vascular endothelial growth factor
11/20/2003US20030215408 Combination antiperspirant and antimicrobial composition
11/20/2003US20030215396 Method for the production of propellant gas-free aerosols from aqueous medicament preparations
11/20/2003US20030215395 Cationic amine polymer, cationic peptide or cationic carbohydrate and at least one degradable linker molecule connecting said cationic molecules in a branched arrangement
11/20/2003US20030215388 Can be administered in conjunction with radiation or chemotherapeutic agents.
11/20/2003US20030213920 Methods for sterilizing preparations containing albumin
11/20/2003CA2823041A1 Fgf variants and methods for use thereof
11/20/2003CA2763775A1 Bisphosphonic acids for the treatment and prevention of osteoporosis
11/20/2003CA2485755A1 Purified composition of bispecific molecules and methods of production
11/20/2003CA2485400A1 Methylated immunostimulatory oligonucleotides and methods of using the same
11/20/2003CA2485125A1 Active carbohydrate containing protecting reagents for chemical modifications, their production and use
11/20/2003CA2484891A1 Conjugates comprising central nervous system active drug
11/20/2003CA2484835A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003CA2484641A1 A method to improve surface properties of pharmaceutical tablets
11/20/2003CA2484637A1 Nanoparticulate nystatin formulations
11/20/2003CA2484607A1 Methods and compositions for inducing an immune response
11/20/2003CA2484266A1 Cancer vaccines and methods of using the same
11/20/2003CA2483914A1 Capsules for dry powder inhalers and methods of making and using same
11/20/2003CA2483696A1 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
11/20/2003CA2483142A1 Use of vegf for treating bone defects
11/19/2003EP1362600A1 Pharmaceutical compositions containing decoy and method of using the same
11/19/2003EP1362599A2 Conjugate of bioegradable aliphatic polyester-based polymer with peptide
11/19/2003EP1362598A1 Active oxygen generator containing photosensitizer for ultrasonic therapy
11/19/2003EP1362584A1 Immediate wettability water soluble film or water soluble layer for oral application
11/19/2003EP1362581A2 Combination antiperspirant and antimicrobial compositions
11/19/2003EP1362053A2 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361899A2 Devices and methods for the treatment of cancer
11/19/2003EP1361898A2 Modulated release particles for aerosol delivery
11/19/2003EP1361895A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1361890A2 Influenza vaccine formulations for intradermal delivery
11/19/2003EP1361881A2 Steroid hormone products and methods for preparing them
11/19/2003EP1361877A1 Pharmaceutical dosage forms of epothilones for oral administration
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361871A2 Medicament formulation containing a muscarinic agonist
11/19/2003EP1361869A2 Transdermal therapeutic system containing testosterone and method for the production thereof
11/19/2003EP1361868A1 Novel modified release formulation
11/19/2003EP1361867A1 Fibrate-statin combinations with reduced fed-fasted effects
11/19/2003EP1361865A2 Cubic liquid crystalline compositions and methods for their preparation
11/19/2003EP1361864A2 Mucoadhesive pharmaceutical formulations
11/19/2003EP1361863A2 Carotenoid-loaded liposomes
11/19/2003EP1361861A1 Modulated release particles for aerosol delivery
11/19/2003EP1361860A1 Modulated release particles for aerosol delivery
11/19/2003EP1361859A1 Modulated release particles for aerosol delivery
11/19/2003EP1361858A2 Modulated release particles for aerosol delivery
11/19/2003EP1361857A1 Modulated release particles for aerosol delivery
11/19/2003EP1361856A1 Gel emulsions in the form of o/w emulsions having a hydrocolloid content
11/19/2003EP1361847A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs
11/19/2003EP1140150B1 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
11/19/2003EP1124549B1 Water-miscible pharmaceutical compositions of paclitaxel
11/19/2003EP1121107B1 Sertraline oral concentrate
11/19/2003EP1027413B1 Fractionated vegetable oil
11/19/2003EP0996442B1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
11/19/2003EP0956048B1 Stable compositions containing a retinoid and an enzyme based antioxidant system
11/19/2003EP0945452B1 Sugar compounds, gelling agents, gelling agent compositions, processes for the preparation of them, and gel compositions
11/19/2003EP0884052B1 Cartilage/bone inducing materials for reparation
11/19/2003EP0851753B1 Aerosol compositions
11/19/2003EP0767673B1 Methods for reduced renal uptake of antibody fragments
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003EP0720485B1 Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
11/19/2003CN1457261A Method and compositions for prevention or treatment of cancer
11/19/2003CN1457260A Reusable extracorporeal colums loaded with ligand-dibiotin conjugates
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1457256A Eye drops
11/19/2003CN1457253A External application for enhancing skin permeability of active components therein
11/19/2003CN1456356A Gene carrier for therapy of cerebral gliocyte diseases
11/19/2003CN1456353A Senile dementia vaccinum and preparing method thereof
11/19/2003CN1456352A Medicinal composition containing fiber eliminating enzyme
11/19/2003CN1456351A Self-emulsifying agglomerant of oral polypeptide medicine
1 ... 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 ... 1712